These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

962 related items for PubMed ID: 17432097

  • 1. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P, Vécsei L.
    Ideggyogy Sz; 2007 Jan 20; 60(1-2):61-4. PubMed ID: 17432097
    [Abstract] [Full Text] [Related]

  • 2. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M, Benecke R.
    MMW Fortschr Med; 2005 May 17; 147 Spec No 2():28-31. PubMed ID: 15968869
    [Abstract] [Full Text] [Related]

  • 3. Rehabilitation goals and strategies in Parkinson's disease.
    Ceravolo MG.
    Eur J Phys Rehabil Med; 2009 Jun 17; 45(2):205-8. PubMed ID: 19532108
    [No Abstract] [Full Text] [Related]

  • 4. [Parkinson's disease].
    Yokochi M.
    Ryoikibetsu Shokogun Shirizu; 1999 Jun 17; (27 Pt 2):5-14. PubMed ID: 10434578
    [No Abstract] [Full Text] [Related]

  • 5. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL, Schmitt L, Bagheri H.
    Rev Neurol (Paris); 2003 Apr 17; 159(4):441-3. PubMed ID: 12773874
    [Abstract] [Full Text] [Related]

  • 6. Recent advances in Parkinson's disease.
    Vécsei L.
    Ideggyogy Sz; 2002 Nov 20; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract] [Full Text] [Related]

  • 7. [Hypersexuality during use of levodopa].
    van Deelen RA, Rommers MK, Eerenberg JG, Egberts AC.
    Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2095-8. PubMed ID: 12448966
    [Abstract] [Full Text] [Related]

  • 8. [Levodopa for Parkinson's disease: What have we learned?].
    Juri C C, Chaná C P.
    Rev Med Chil; 2006 Jul 02; 134(7):893-901. PubMed ID: 17130974
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing dopaminergic therapy of Parkinson's disease.
    Horowski R.
    Funct Neurol; 1988 Jul 02; 3(4):459-70. PubMed ID: 2907501
    [No Abstract] [Full Text] [Related]

  • 10. NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.
    Varanese S, Howard J, Di Rocco A.
    Mov Disord; 2010 Mar 15; 25(4):508-10. PubMed ID: 20014061
    [No Abstract] [Full Text] [Related]

  • 11. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R.
    Neurosci Biobehav Rev; 2006 Mar 15; 30(1):1-23. PubMed ID: 15935475
    [Abstract] [Full Text] [Related]

  • 12. Levodopa in the treatment of Parkinson's disease: current controversies.
    Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F.
    Mov Disord; 2004 Sep 15; 19(9):997-1005. PubMed ID: 15372588
    [Abstract] [Full Text] [Related]

  • 13. [Drug therapy of Parkinson's disease].
    Myllylä V.
    Duodecim; 1997 Sep 15; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract] [Full Text] [Related]

  • 14. Recent advances in pharmacological therapy of Parkinson's disease.
    Riederer P, Lange KW, Youdim MB.
    Adv Neurol; 1993 Sep 15; 60():626-35. PubMed ID: 8093582
    [Abstract] [Full Text] [Related]

  • 15. Levodopa in the early treatment of Parkinson's disease.
    Murata M.
    Parkinsonism Relat Disord; 2009 Jan 15; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [Abstract] [Full Text] [Related]

  • 16. Levodopa for the treatment of Parkinson's disease.
    Lewitt PA.
    N Engl J Med; 2008 Dec 04; 359(23):2468-76. PubMed ID: 19052127
    [No Abstract] [Full Text] [Related]

  • 17. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr 04; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 18. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG.
    Neurology; 2006 May 23; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract] [Full Text] [Related]

  • 19. [Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review].
    Bode M.
    Ugeskr Laeger; 2009 Oct 05; 171(41):2996-9. PubMed ID: 19814927
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic strategies in Parkinson's disease].
    Shoulson I.
    Arch Neurobiol (Madr); 1991 Oct 05; 54(6):277-81. PubMed ID: 1687429
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.